Trial NCT01970527

View at ClinicalTrials.gov 
Org. Study IDs: 9031
Secondary IDs: 9031 NCI-2013-01757 P30CA015704

Last trial update was posted on 2020-02-13

MeSH Interventions

Ipilimumab

MeSH Conditions

Melanoma

Other Conditions

Recurrent Melanoma Stage IV Skin Melanoma

Stopping Reasons

Change in standard of care

Limitations And Caveats

We stopped this trial early as the standard of care shifted during the course of the study. Participant flow, Baseline Characteristics and Adverse events were recorded as appropriate for the 23 patients (22 evaluable) who consented to the trial.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID